上海创诺制药有限公司
Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
25
NMPA:25
Drug Approvals
Bendamustine Hydrochloride for Injection
- Product Name
- 注射用盐酸苯达莫司汀
- Approval Number
- 国药准字H20244529
- Approval Date
- Jul 30, 2024
NMPA
Erlotinib Hydrochloride Tablets
- Product Name
- 盐酸厄洛替尼片
- Approval Number
- 国药准字H20204030
- Approval Date
- Jun 12, 2024
NMPA
Erlotinib Hydrochloride Tablets
- Product Name
- 盐酸厄洛替尼片
- Approval Number
- 国药准字H20193262
- Approval Date
- Jun 12, 2024
NMPA
Sorafenib Tosylate Tablets
- Product Name
- 甲苯磺酸索拉非尼片
- Approval Number
- 国药准字H20234644
- Approval Date
- Dec 13, 2023
NMPA
- Prev
- 1
- 2
- 3
- Next
Clinical Trials
No trials found
News
No news found